Genotype-Guided Warfarin Therapy Trial

NCT00904293 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Deep Vein Thrombosis
Pulmonary Embolism
Artificial Heart Valve

Interventions

OTHER: Genotype-guided dose determination
OTHER: Non-genotype guided warfarin dosing

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]